Rheumatoid arthritis (RA) with concomitant hepatitis B virus (HBV) infection represents a therapeutic challenge due to the risk of HBV reactivation under immunosuppressive treatment. To date there are few data concerning the HBV reactivation following treatment with abatacept coming from anecdotal case reports. This observational retrospective study was aimed to assess the safety profile of abatacept in this particular clinical setting.

Safety of abatacept in rheumatoid arthritis with serological evidence of past or present hepatitis B virus infection

PADOVAN, Melissa
Primo
;
TROTTA, Francesco;GRILLI, Anastasio;GOVONI, Marcello
Ultimo
2016

Abstract

Rheumatoid arthritis (RA) with concomitant hepatitis B virus (HBV) infection represents a therapeutic challenge due to the risk of HBV reactivation under immunosuppressive treatment. To date there are few data concerning the HBV reactivation following treatment with abatacept coming from anecdotal case reports. This observational retrospective study was aimed to assess the safety profile of abatacept in this particular clinical setting.
2016
Padovan, Melissa; Filippini, Matteo; Tincani, Angela; Lanciano, Elisabetta; Bruschi, Eleonora; Epis, Oscar; Garau, Pietro; Mathieu, Alessandro; Celletti, Eleonora; Giani, Leopoldo; Tomietto, Paola; Atzeni, Fabiola; Sarzi Puttini, Piercarlo; Zuliani, Francesca; De Vita, Salvatore; Trotta, Francesco; Grilli, Anastasio; Puoti, Massimo; Govoni, Marcello
File in questo prodotto:
File Dimensione Formato  
Padovan_et_al-Arthritis_Care_&_Research.pdf

accesso aperto

Descrizione: post print
Tipologia: Post-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 658.72 kB
Formato Adobe PDF
658.72 kB Adobe PDF Visualizza/Apri
acr.22786.pdf

accesso aperto

Descrizione: versione editoriale
Tipologia: Full text (versione editoriale)
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 111.86 kB
Formato Adobe PDF
111.86 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2335066
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 44
social impact